330 related articles for article (PubMed ID: 11992745)
1. Renal effects of cyclooxygyenase-2-selective inhibitors.
Brater DC
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
[TBL] [Abstract][Full Text] [Related]
2. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
Chiolero A; Würzner G; Burnier M
Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
[TBL] [Abstract][Full Text] [Related]
3. Renal effects of nonselective NSAIDs and coxibs.
Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI53-8. PubMed ID: 12086295
[TBL] [Abstract][Full Text] [Related]
4. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors.
Gambaro G; Perazella MA
J Intern Med; 2003 Jun; 253(6):643-52. PubMed ID: 12755960
[TBL] [Abstract][Full Text] [Related]
5. Renal effects of COX-2-selective inhibitors.
Brater DC; Harris C; Redfern JS; Gertz BJ
Am J Nephrol; 2001; 21(1):1-15. PubMed ID: 11275626
[TBL] [Abstract][Full Text] [Related]
6. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
Zhao SZ; Reynolds MW; Lejkowith J; Whelton A; Arellano FM
Clin Ther; 2001 Sep; 23(9):1478-91. PubMed ID: 11589261
[TBL] [Abstract][Full Text] [Related]
7. NSAIDs and the kidney revisited: are selective cyclooxygenase-2 inhibitors safe?
Eras J; Perazella MA
Am J Med Sci; 2001 Mar; 321(3):181-90. PubMed ID: 11269794
[TBL] [Abstract][Full Text] [Related]
8. COX-2 and the kidneys.
Stichtenoth DO; Frölich JC
Curr Pharm Des; 2000 Nov; 6(17):1737-53. PubMed ID: 11102561
[TBL] [Abstract][Full Text] [Related]
9. COX-2 inhibitors and the kidney.
Appel GB
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S37-40. PubMed ID: 11695250
[TBL] [Abstract][Full Text] [Related]
10. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
Giovanni G; Giovanni P
J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins and renal damage.
Navarro JF
J Am Soc Nephrol; 1996 Aug; 7(8):1245-6. PubMed ID: 8866420
[No Abstract] [Full Text] [Related]
12. A comparison of adverse renovascular experiences among osteoarthritis patients treated with rofecoxib and comparator non-selective non-steroidal anti-inflammatory agents.
Gertz BJ; Krupa D; Bolognese JA; Sperling RS; Reicin A
Curr Med Res Opin; 2002; 18(2):82-91. PubMed ID: 12017215
[TBL] [Abstract][Full Text] [Related]
13. [Coxibs: cyclooxygenase-2 inhibitors].
Turnheim K
Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
[TBL] [Abstract][Full Text] [Related]
14. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.
Noroian G; Clive D
Drug Saf; 2002; 25(3):165-72. PubMed ID: 11945113
[TBL] [Abstract][Full Text] [Related]
15. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
16. Current perspective on the cardiovascular effects of coxibs.
Konstam MA; Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
[TBL] [Abstract][Full Text] [Related]
17. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
Hochberg MC
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
[TBL] [Abstract][Full Text] [Related]
18. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
19. New NSAIDs and gastroduodenal damage.
Folco GC
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
[TBL] [Abstract][Full Text] [Related]
20. [Specific COX-2 inhibitors: prospects of therapy with new analgesic and anti-inflammatory substances].
Hinz B; Brune K
Wien Klin Wochenschr; 1999 Feb; 111(3):103-12. PubMed ID: 10093892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
